SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
准哥
Lv1
70 积分
2023-05-26 加入
最近求助
最近应助
互助留言
Basic Regulatory Science Behind Drug Substance and Drug Product Specifications of Monoclonal Antibodies and Other Protein Therapeutics
24天前
已完结
Demonstrating analytical similarity of a biosimilar HLX04 to bevacizumab with a panel of state-of-the-art methods and tiering of quality attributes
24天前
已完结
Abstract 1781: HPN536, a T cell-engaging, mesothelin/CD3-specific TriTAC for the treatment of solid tumors
2个月前
已关闭
Cadonilimab: First Approval
4个月前
已完结
CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia
5个月前
已完结
CRISPR/Cas9-based gene-editing technology for sickle cell disease
5个月前
已完结
Is CRISPR safe? Genome editing gets its first FDA scrutiny
5个月前
已完结
CRISPR-Mediated Genome Engineering in Cell Lines
10个月前
已关闭
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
11个月前
已完结
Demonstrating analytical similarity of a biosimilar HLX04 to bevacizumab with a panel of state-of-the-art methods and tiering of quality attributes
11个月前
已完结
没有进行任何应助
感谢,速度真快
24天前
感谢,速度真快
24天前
感谢
5个月前
速度真快,么么哒,速度真快,点赞
5个月前
感谢
5个月前
速度真快,点赞,感谢
11个月前
感谢,点赞,么么哒
11个月前
点赞,速度真快,帮大忙了,么么哒
1年前
速度真快,帮大忙了,感谢
1年前
速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
是的,大家可以多推广推广
24天前